Jasper Total Current Assets from 2010 to 2024
| JSPR Stock | USD 23.10 0.13 0.56% |
Total Current Assets | First Reported 2010-12-31 | Previous Quarter 88.9 M | Current Value 58.6 M | Quarterly Volatility 22.3 M |
Check Jasper Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jasper main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Selling General Administrative of 11.2 M or Other Operating Expenses of 40.4 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.1. Jasper financial statements analysis is a perfect complement when working with Jasper Therapeutics Valuation or Volatility modules.
Jasper | Total Current Assets |
Latest Jasper Therapeutics' Total Current Assets Growth Pattern
Below is the plot of the Total Current Assets of Jasper Therapeutics over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Jasper Therapeutics' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jasper Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Total Current Assets | 10 Years Trend |
|
Total Current Assets |
| Timeline |
Jasper Total Current Assets Regression Statistics
| Arithmetic Mean | 37,960,771 | |
| Geometric Mean | 33,814,263 | |
| Coefficient Of Variation | 58.86 | |
| Mean Deviation | 16,700,464 | |
| Median | 27,163,000 | |
| Standard Deviation | 22,344,924 | |
| Sample Variance | 499.3T | |
| Range | 68.3M | |
| R-Value | 0.63 | |
| Mean Square Error | 321.7T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | 3,167,010 | |
| Total Sum of Squares | 6990.1T |
Jasper Total Current Assets History
About Jasper Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Jasper Therapeutics income statement, its balance sheet, and the statement of cash flows. Jasper Therapeutics investors use historical funamental indicators, such as Jasper Therapeutics's Total Current Assets, to determine how well the company is positioned to perform in the future. Although Jasper Therapeutics investors may use each financial statement separately, they are all related. The changes in Jasper Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Jasper Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Jasper Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Jasper Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Assets | 88.9 M | 58.6 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Jasper Therapeutics Correlation against competitors. To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Jasper Stock analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Jasper Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jasper Therapeutics. If investors know Jasper will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jasper Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (61.80) | Return On Assets (0.60) | Return On Equity (1.13) |
The market value of Jasper Therapeutics is measured differently than its book value, which is the value of Jasper that is recorded on the company's balance sheet. Investors also form their own opinion of Jasper Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Jasper Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jasper Therapeutics' market value can be influenced by many factors that don't directly affect Jasper Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jasper Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jasper Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jasper Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.